Acquisitions, Dispositions and Other Transactions (Tables)

9 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

Schedule of Assets Acquired and Liabilities Assumed

The following summary represents the second preliminary fair value of Kleeneze as of the acquisition date, March 24, 2015. This is significantly adjusted from the second quarter 2015 preliminary fair values estimated due to completion of the purchase price allocation, which remains open subject to finalization which is expected in the fourth quarter of 2015, that occurred in September 2015. As a result of the purchase price allocation, we have recognized a preliminary bargain purchase gain of approximately $2.8 million. Although this gain had not been reported in a Form 10-Q filed previously in 2015, this gain is recognized as of March 31, 2015. Therefore, this gain is reflected in the nine months ended September 30, 2015 Statement of Operations, but it is not reflected in the three months ended September 30, 2015 Statement of Operations. 

	(in thousands)
Consideration	$	5,100
Amounts recognized for assets acquired and liabilities assumed:
Current assets	12,163
Other long-term assets	619
Identifiable intangible assets	2,239
Current liabilities	(6,353		)
Other long-term liabilities (a)	(750		)
Net assets acquired	7,918
Gain on acquisition of Kleeneze	$	(2,819	)
(a) The other long-term liabilities includes $750,000 of deferred tax liability generated as part of the acquisition. This deferred tax liability was directly offset against the gain on the acquisition.

Business Acquisition, Pro Forma Information

The following unaudited pro-forma financial information presents the Company's consolidated financial results for the three and nine months ended September 30, 2015 and 2014 as if the acquisition had occurred as of January 1, 2014 (in thousands, except per share data):

	Nine Months Ended September 30,
	2015			2014
Operations
Revenues	$	104,727		$	121,874
Net loss	(13,581		)	(14,926		)
Net loss attributable to CVSL Inc.	(10,646		)	(12,201		)
Loss per common share attributable to CVSL Inc., basic and diluted	$	(0.32	)	$	(0.25	)

Notes to Pro-forma Unaudited Condensed Consolidated Financial Statement

These pro-forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations that actually would have resulted had the acquisition been effective at the beginning of the respective periods and are not necessarily representative of future results. The pro-forma results include the following adjustments:

• Losses were incurred as a result of the write down of intercompany receivables in the amount of $33.1 million that were forgiven prior to and in accordance with the transaction. As these losses were direct and one-time events related specifically to the acquisition, we have excluded these items from the pro-forma financials above;

• The pro-forma results above exclude $113,000 in transaction costs.